Skip to content

BioVantage: A Programmable Interluminal Contraction Augmentation System

A quick deployment, minimally invasive emergency care device with a low risk profile for acute Heart Failure patients with reduced EF

Published: 19th November 2021
BioVantage: A Programmable Interluminal Contraction Augmentation System
abhijith3747, stock.adobe.com
IP Status
  • Patent application submitted
Seeking
  • Licensing
  • Development partner
  • Commercial partner